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Abstract
Introduction: Gestational diabetes mellitus (GDM) is associated with an increased frequency of gestational, perinatal and neonatal com-
plications. The aim of the study was to evaluate risk factors for GDM and their predictive value.
Material and methods: The group studied consisted of 510 pregnant women with GDM diagnosed according to World Health Organiza-
tion (WHO) criteria (GDM). The controls were 1160 pregnant women with normal glucose tolerance (NGT). Multifactorial analysis was
performed and odds ratios (OR) were calculated for each risk factor identified.
Results: The GDM patients were significantly older than the NGT subjects (30.1 vs. 27.2 years; p < 0.0001), had a greater tendency towards
obesity before pregnancy (BMI 25.0 vs. 21.6 kg/m2; p < 0.0001), more often had relatives with diabetes (40.0 vs. 25.7%; p < 0.01), had greater
parity (third or subsequent pregnancy: 33.6 vs. 16.0%; p < 0.001) and more often experienced adverse perinatal outcomes (21.4 vs. 13.7%;
p < 0.01). Multivariate analysis revealed the following risk factors for GDM: BMI > 25 kg/m2 (OR 4.14), a history of macrosomia (OR 2.72),
being pregnant for the third time or more (OR 1.8), a family history of diabetes (OR 1.76) and age at gestation > 25 years (OR 1.34). No risk
factors were present in 12% of GDM subjects, and at least one risk factor was found in 74.1% of subjects with NGT. No risk factor cluster
was found which could be used easily in everyday practice to identify reliably subjects at increased risk of GDM.
Conclusions: Age, overweight and obesity, diabetes in the family, parity, macrosomia and a history of perinatal complications were
identified as risk factors for GDM. As no reliable method of identifying subjects at increased GDM risk was found, we suggest that all
pregnant women should undergo laboratory screening for GDM. (Pol J Endocrinol 2008; 59 (5): 393–397)
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Streszczenie
Wstęp: Cukrzyca ciążowa (GDM, Gestational Diabetes Mellitus) zwiększa ryzyko powikłań ciąży, porodu i powikłań u noworodka. Celem
pracy była ocena czynników ryzyka zachorowania na cukrzycę ciążową i ich wartości predykcyjnych.
Materiał i metody: Do grupy badanej włączono 510 ciężarnych kobiet z rozpoznaną według kryteriów Światowej Organizacji Zdrowia
(WHO, World health Organization) cukrzycą ciążową (grupa GDM, gestational diabetes mellitus). Grupę kontrolną stanowiło 1160 kobiet
z prawidłową gospodarką węglowodanową w ciąży (grupa NGT, normal glucose tolerance). Dla rozpoznanych czynników ryzyka cukrzycy
ciążowej wykonano analizę wieloczynnikową oraz wyliczono iloraz szans.
Wyniki: Pacjentki z GDM były starsze (30,1 vs. 27,2 lat; p < 0,0001), miały wyższy BMI przed ciążą (25,0 vs. 21,6 kg/m2; p < 0,0001), częściej
miały krewnych z cukrzycą (40.0 vs. 25,7%; p < 0,01), częściej były wieloródkami (33,6 vs. 16,0%; p < 0,001) i częściej przebyły niepowodze-
nia położnicze (21,4 vs. 13,7%; p < 0,01) niż kobiety z NGT. Na podstawie analizy wieloczynnikowej wyłoniono następujące czynniki
ryzyka GDM: BMI > 25 kg/m2 (OR 4,14); urodzenie dziecka z makrosomią (OR 2,72), 3 lub następne ciąże (OR 1,8), pozytywny wywiad
rodzinny w kierunku cukrzycy (OR 1,76) oraz wiek > 25 lat (OR 1,34). U 12% ciężarnych z GDM nie stwierdzono żadnego czynnika
ryzyka, a przynajmniej jeden czynniki ryzyka stwierdzono u 74,1% ciężarnych bez zaburzeń tolerancji glukozy w ciąży. Nie udało się
znaleźć takiego zestawu czynników ryzyka, który pozwoliłby wyłonić pacjentki z wysokim ryzykiem cukrzycy ciążowej z ogółu ciężar-
nych.
Wnioski: Wiek, nadwaga i otyłość, rodzinne obciążenie cukrzycą, rodność, makrosomia i niepowodzenia w wywiadzie położniczym są
czynnikami ryzyka cukrzycy ciążowej. Ze względu na brak możliwości wyłonienia na podstawie obecności czynników ryzyka kobiet
szczególnie zagrożonych cukrzycą ciążową, laboratoryjne badania przesiewowe powinny być wykonywane u wszystkich ciężarnych.
(Endokrynol Pol 2008; 59 (5): 393–397)
Słowa kluczowe: cukrzyca ciążowa, czynniki ryzyka, badania przesiewowe
394
Risk factors of gestational diabetes Katarzyna Cypryk et al.
PR
A
C
E 
O
R
Y
G
IN
A
LN
E
Introduction
The prevalence of gestational diabetes mellitus (GDM)
is estimated at 2–4% of all pregnancies in various po-
pulations, although there have been reports of preva-
lence as low as 0.5% in low-risk populations and as high
as 10% in subjects with multiple diabetes risk factors.
GDM prevalence reported in Poland varies from 1.9 to
3.8% in different regions and these numbers are within
the range reported for Caucasians. Some studies sug-
gest that GDM prevalence is related to general diabetes
prevalence in a given community [1–6].
Diagnostic criteria and methods have a direct im-
pact on the prevalence of GDM. In many countries scre-
ening for glucose intolerance in pregnancy is not routi-
nely conducted, even if recommended [7, 8]. Specifi-
cally, in Poland, despite the clear guidelines published
by the Polish Diabetes Association in 1994, screening
procedures are still not performed in the majority of
pregnancies [9]. The identification of GDM risk factors,
which is likely to result in increased screening of sub-
jects at greater risk of developing GDM, is therefore of
utmost importance.
The first screening criteria for gestational diabetes
were proposed in 1973 by O’Sullivan [10]. At present,
GDM screening and diagnostic protocols are operating
in many countries, although these procedures are not
standardised. In 1999 the American Diabetes Associa-
tion (ADA) and the World Health Organization (WHO)
issued independently their guidelines on GDM diagno-
sis. These two documents are distinctly different. The
ADA ceased to recommend screening procedures at
a population level and limits their use to women with
risk factors for GDM. Female subjects with no family
history of diabetes, under 25 years of age and with nor-
mal body mass, are at low risk of GDM occurrence and,
according to ADA recommendations, need not be sub-
ject to screening examination [11, 12]. These recommen-
dations aim at decreasing the costs of diagnostics, as it
is estimated that universal screening would involve as
many as three million screening tests in the United Sta-
tes annually [13]. The WHO does not preclude screening
to a particular group of women. According to WHO gu-
idelines the 75 g oral glucose tolerance test (OGTT) is
recommended for GDM diagnosis with the same cut-off
values for blood glucose as for the general population.
Impaired glucose tolerance (IGT) is considered GDM.
The aim of this study was to assess the prevalence
of risk factors for GDM and their significance for dia-
gnosis of the disorder.
Material and methods
Material and glucose assay method
The study was conducted in the Research Institute of
the Hospital of the Polish Mother, Łódź, Poland over a
10-year period. A total of 1670 pregnant Caucasian wo-
men attending the obstetrics and gynaecology outpa-
tient department were enrolled in the study. The pa-
tients, supervised by trained research nurses, filled in
a standardised questionnaire comprising questions to
elicit a detailed family history of diabetes in close and
distant relatives (covering patients’ parents, parents’ si-
blings, grandparents, the patients’ own siblings, their
children and their cousins), age at conception, obstetric
history, and pregestational body mass index (BMI). All
patients were also examined by a physician. The same
procedures were followed for all the patients included
in the study, GDM cases and controls alike. The study
group consisted of 510 pregnant women with GDM,
diagnosed according to WHO and Polish Diabetes As-
sociation criteria (GDM). The control group comprised
1160 pregnant women with normal glucose tolerance
(NGT). Plasma glucose was measured during a glucose
challenge test with the use of hexokinase (the referen-
ce method). All biochemical assays were performed with
the COBAS-INTEGRA analyser.
Statistical analysis
Differences between the means were assessed with the
use of Student’s t-test after confirming normal distribu-
tion of the data with the Shapiro-Wilk test; otherwise
the non-parametric Mann-Whitney U test was used. The
c2 or Fisher’s exact test (depending on group count)
were used to assess the differences in distribution of
qualitative parameters such as the history of macroso-
mia. Uni- and multivariable logistic regression were
used to measure the effect of risk factors on the proba-
bility of GDM occurrence. Sensitivity, specificity and
positive and negative predictive values were calcula-
ted [14, 15].
In all statistical tests the level of significance was ac-
cepted at 0.05. Statistical calculations were performed with
the use of SPSS v. 6.0 and EGRET software packages.
Results
The GDM subjects were found to be significantly older
than the NGT subjects: 30.1 ± 5.9 vs. 27.2 ± 4.9 yrs
(p < 0.0001). Mean BMI was significantly higher in the
GDM group than in subjects with NGT: 25.0 ± 5.1 vs.
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Table I. The prevalence of risk factors of gestational diabetes in GDM and NGT groups
Tabela I. Występowanie czynników ryzyka cukrzycy ciążowej w grupach GDM i NGT
Risk factor GDM (n = 510) NGT (n = 1160) p
n % n %
Age at conception > 25 years 378 74.1 676 58.3  < 0.001
Pregestational BMI > 25 kg/m2 200 39.4 128 11.2  < 0.001
Obstetrical failure 109 21.4 304 13.7  < 0.001
History of macrosomia 56 11.0 25 2.2  < 0.001
≥ 3 pregnancies 171 33.6 186 16.0  < 0.001
Family history of diabetes 204 40.0 298 25.7  < 0.001
Table II. Odds ratio (OR) for GDM for each risk factor
analysed — the results of univariate analysis
Tabela II. Iloraz szans poszczególnych czynników ryzyka
cukrzycy ciążowej — wyniki analizy jednoczynnikowej
Risk factor OR 95% CI p
History of macrosomia 5.60 3.45–9.08  < 0.05
Pregestational BMI > 25 kg/m2 5.16 3.99–6.65  < 0.05
≥ 3 pregnancies 2.65 2.08–3.37  < 0.05
Age at conception > 25 yrs 2.05 1.63–2.58  < 0.05
Family history of diabetes 1.93 1.55–2.40  < 0.05
Obstetrical failure 1.72 1.31–2.25  < 0.05
95% CI — 95% confidence interval
Table III. Relative risk (expressed as odds ratio [OR]) of GDM
in multivariate analysis
Tabela III. Ryzyko względne (wyrażone jako iloraz szans)
cukrzycy ciążowej — analiza wieloczynnikowa
Risk factor OR 95% CI p
Pregestational BMI > 25 kg/m2 4.14 3.17–5.42  < 0.001
History of macrosomia 2.72 1.60–4.65  < 0.001
≥ 3 pregnancies 1.80 1.30–2.49  < 0.001
Family history of diabetes 1.76 1.38–2.24  < 0.001
Age at conception > 25 years 1.34 1.04–1.73 0.023
Obstetrical failure 1.00 0.71–1.42  > 0.05
95% CI — 95% confidence interval
21.6 ± 3.3 kg/m2 (p < 0.0001). In obese patients (BMI
≥ 30 kg/m2) GDM occurrence was four times higher than
in women with normal body weight, and almost twice
as high as in overweight subjects (BMI 25–30 kg/m2).
The prevalence of the analysed risk factors in both gro-
ups is given in Table I.
Each analysed risk factor was found significantly
more often in the subjects with GDM than in those with
NGT. Odds ratios for GDM occurrence were calculated
for each risk factor. In the absence of a given risk factor
the OR equalled 1. In the univariate analysis the most
significant risk factor for prediction of GDM occurren-
ce was foetal macrosomia in previous pregnancies, as
this increased the risk more than fivefold (OR 5.6) when
compared to women who had had children with nor-
mal birth weights in previous pregnancies. Excessive
body weight before pregnancy was also a strong risk
factor (OR 5.16). The results of univariate analysis are
presented in Table II.
Multivariate logistic regression analysis demonstra-
ted that the risk of GDM was significantly increased in
women with: BMI > 25 kg/m2, three or more previous
pregnancies, a family history of diabetes, > 25 years and
a history of macrosomia (Table III).
The sensitivity, specificity and positive and negati-
ve predictive values for all the risk factors analysed are
presented in Table IV. No one factor of those analysed
was sufficiently strong in the recognition of GDM.
Co-existence of the risk factors was analysed in the
subjects studied. The distribution of multiple risk fac-
tors was differed significantly between the two groups
(p < 0.0005) (Table V). Of the women with GDM, 12%
had no risk factors, while only a quarter of the NGT
subjects presented no risk factors.
In order to determine whether a single or combina-
tion of risk factors would improve the identification of
those with GDM, both multiple logistic regression ana-
lysis and linear/square discriminative analysis were
undertaken. However, neither model had sufficient
predictive power. The use of multiple logistic regres-
sion analysis enabled only 31.8% of future GDM cases
to be identified (i.e. only 31.8% of those subjects for
whom the model predicted GDM development actual-
ly had GDM according to OGTT results), and for squ-
are discriminative analysis the figure was 46.9%, so that
by risk factors alone at best only 240 out of 510 women
with GDM would have been identified. Concordance
of both models with the OGTT results for NGT ranged
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Table IV. Sensitivity, specificity and positive and negative predictive values for each risk factor analysed
Tabela IV. Czułość, swoistość, pozytywna i negatywna wartość predykcyjna poszczególnych czynników ryzyka cukrzycy
ciążowej
Risk factor Sensitivity Specificity Positive predictive value Negative predictive value
History of macrosomia 11.0 97.8 69.1 71.4
Pregestational BMI > 25 kg/m2 39.2 89.0 61.0 76.9
≥ 3 pregnancies 33.5 84.0 47.9 74.2
Age at conception > 25 years 74.1 41.7 35.9 78.6
Family history of diabetes 40.0 74.3 46.0 73.8
Obstetrical failure 21.4 73.8 26.4 68.1
Table V. Distribution of risk factors in the groups studied
Tabela V. Rozkład czynników ryzyka w badanych grupach
Study groups No. of risk factors
0 1 2 3 4 5 or 6
GDM* (%) 12.0 22.7 26.7 19.4 12.2 7.1
NGT (%) 25.9 39.1 21.5 9.7 3.0 0.8
*Prevalence distributions in GDM and NGT are significantly different (p < 0.0001)
from 84–94%. Thus, while both methods were able to
identify those without GDM, neither model could ac-
curately identify even half of the women with GDM
according to the OGTT.
Discussion
It has been well established that several genetic and con-
stitutional factors are associated with susceptibility to the
development of GDM. Most authors consider older age,
being overweight, a family history of diabetes, multipari-
ty, macrosomia in earlier pregnancies and previous GDM
or IGT as the best predictors of GDM [1, 2, 5, 16–18].
In our study the subjects with GDM were signifi-
cantly older and had a greater tendency to obesity than
women with NGT. An age over 25 years and excessive
body mass before pregnancy has been shown to incre-
ase the risk of gestational diabetes by 50–220%. Three
quarters of the women with GDM were older than 25
years in comparison with slightly more than half in the
non-diabetes group. Diabetic women were more often
overweight than non-diabetes subjects: 39.4 vs. 11.2%
(p < 0.0005). An age > 25 years increased the risk of
GDM almost twofold (RR 2.05), and BMI > 25 kg/m2
over fivefold (RR 5.16). These findings are in agreement
with the results of many other authors [5, 16–19].
A family history of diabetes is another similarity be-
tween GDM and type 2 diabetes. In our study 40% of
GDM patients and 20.4% of women with NGT claimed
to have a first degree relative with diabetes (p < 0.05).
Family history of diabetes was a strong risk factor for
GDM, as it increased the risk by 90%. Salomon et al.
found this factor to increase the risk by 68% [18]. In the
light of a number of studies, a family history of diabetes
seems to be a reliable predictor of GDM, although it
should always be regarded with caution, as some pa-
tients may not be aware, for a variety of reasons, of
medical conditions which afflict their relatives [20, 21].
Multiparity was found to be a significant risk factor
for GDM. In contrast to our findings, the studies by
Vamberque, Berkus, Griffin et al. did not find any cor-
relation between parity and diabetes, but the cohorts
studied were women with a mild degree of hypergly-
caemia (one abnormal value in 100 g OGTT) [16, 22, 23].
Bearing a child of birth weight > 4000 g was also a si-
gnificant risk factor for GDM. This was also found in
the study performed by Ogonowski et al. in a Polish
population [5]. Adams et al. reported macrosomia as
high as 44% in undiagnosed GDM. Similar findings
were published by Nasrat [24, 25]. Other authors have
observed an increased frequency of macrosomia in
women in whom GDM was not confirmed but who had
one abnormal value in diagnostic tests [26, 27].
Although many authors have reported that the fac-
tors mentioned in the current study significantly incre-
ase the risk of GDM, there is some dispute as to be be-
nefits of universal screening as opposed to screening
by specific risk factors [16, 21, 27].
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Clearly, while risk factors appear to be more likely
to be present in women with GDM than in women wi-
thout the disease, they are neither sufficiently sensitive
nor specific. In our study one risk factor for GDM was
found in 88% of the diabetes subjects and in 74.1% of
the healthy women. Of all the GDM subjects 12% had
no risk factors whatsoever. In the studies in a Polish
population risk factors were present in 44.4% to 68.4%
of the groups [4, 28]. Other studies show that one or
more GDM risk factors may be found in from 20 to 90%
of pregnant women [27, 29, 30].
Had the testing for GDM been performed only in
the subjects with at least one risk factor, 61 women with
GDM would have gone undetected and therefore untre-
ated. Most studies agree that subsequently at least 20 of
these women would have experienced an adverse per-
inatal outcome. Moreover, multivariate regression and
square discrimination models failed to create a confi-
guration of risk factors which would significantly in-
crease the probability of GDM occurrence and reduce
the number of subjects requiring further testing. We-
eks et al. report that they would have missed 43% of
GDM cases had they tested only at-risk subjects. In this
group over 50% of the subjects needed insulin to con-
trol their diabetes [30]. These findings are in agreement
with our results and support the argument for testing
glucose tolerance in all pregnant women, and not in
only those at increased risk of GDM.
Conclusions
Age, obesity, diabetes in the family, parity, macro-
somia and perinatal complications have been identified
as risk factors for GDM. Nevertheless, a substantial num-
ber of women with GDM present with none of these
risk factors, and their specificity and sensitivity in the
recognition of GDM are very low. We believe that, as
no reliable method has been found using risk factor clu-
stering to identify subjects at increased risk of GDM, all
pregnant women should be screened for gestational
diabetes mellitus.
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